Dow Up 0.15% Nasdaq Up 0.21%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
161.53 Down 1.88(1.15%) 4:00PM EDT
|After Hours : 161.53 0.00 (0.00%) 4:30PM EDT
Prev Close:163.41
Open:164.31
Bid:161.53 x 300
Ask:161.54 x 2400
1y Target Est:198.65
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:160.51 - 164.62
52wk Range:100.89 - 185.43
Volume:968,119
Avg Vol (3m):1,161,710
Market Cap:31.95B
P/E (ttm):97.66
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 1.15%31.95B
AMGNUp 0.99%106.88B
BAXDown 3.12%39.35B

Key Statistics

Forward P/E (1 yr):28.09
P/S (ttm):16.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback